Compare PRCH & CERT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PRCH | CERT |
|---|---|---|
| Founded | 2012 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Retail: Computer Software & Peripheral Equipment |
| Sector | Technology | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 860.9M |
| IPO Year | 2019 | 2020 |
| Metric | PRCH | CERT |
|---|---|---|
| Price | $10.48 | $5.90 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 10 |
| Target Price | ★ $18.63 | $11.67 |
| AVG Volume (30 Days) | 1.9M | ★ 3.5M |
| Earning Date | 04-28-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 90.91 | 87.50 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $482,414,000.00 | $418,838,000.00 |
| Revenue This Year | $4.15 | $4.18 |
| Revenue Next Year | $17.05 | $5.39 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 10.18 | 8.75 |
| 52 Week Low | $6.36 | $4.45 |
| 52 Week High | $19.44 | $13.88 |
| Indicator | PRCH | CERT |
|---|---|---|
| Relative Strength Index (RSI) | 60.61 | 58.09 |
| Support Level | $9.06 | $5.19 |
| Resistance Level | $10.85 | $6.47 |
| Average True Range (ATR) | 0.56 | 0.36 |
| MACD | -0.08 | 0.11 |
| Stochastic Oscillator | 62.82 | 88.68 |
Porch Group Inc is a vertical software company reinventing the home services and insurance industries. It has four reportable segments: Insurance Services, Software & Data, Consumer Services, and Corporate. The majority of revenue is from the Insurance segment. The Insurance Services segment manages and operates the Reciprocal, providing services related, but not limited, to underwriting, policy renewal, risk management, insurance portfolio management, financial management, and setting investment guidelines in exchange for commissions and fees.
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval, and increase patient access to medicines. The company has its business presence in the Americas, which is also its key revenue-generating market, EMEA, and the Asia Pacific region.